
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.3B | -- | -- | $0.27 | -- |
08/08/2025 | Q2 | $1.3B | -- | -- | $0.23 | -- |
05/01/2025 | Q1 | $1.1B | $1.1B | $2.88 | $0.07 | $2.81 |
02/26/2025 | Q4 | $1.1B | $1.2B | -$0.05 | $0.03 | -$0.08 |
11/07/2024 | Q3 | $1.4B | $1.1B | -$0.23 | $0.30 | -$0.53 |
08/08/2024 | Q2 | $1.2B | $1.4B | $0.13 | -$0.00 | $0.13 |
05/09/2024 | Q1 | $1.1B | $1.2B | -$1.77 | -$0.24 | -$1.53 |
02/29/2024 | Q4 | $1.5B | $2.1B | -$2.55 | $0.06 | -$2.61 |
11/09/2023 | Q3 | -- | -- | -$3.98 | $0.14 | -$4.12 |
08/03/2023 | Q2 | -- | -- | -$0.55 | $0.38 | -$0.93 |
05/04/2023 | Q1 | -- | -- | -$0.06 | $0.35 | -$0.41 |
02/23/2023 | Q4 | -- | -- | -$5.39 | $0.48 | -$5.87 |
11/03/2022 | Q3 | -- | -- | $0.04 | $0.46 | -$0.42 |
08/04/2022 | Q2 | -- | -- | -$0.36 | $0.29 | -$0.65 |
05/05/2022 | Q1 | -- | -- | -$0.75 | $0.22 | -$0.97 |
02/17/2022 | Q4 | -- | -- | -$0.50 | $0.17 | -$0.67 |
11/04/2021 | Q3 | -- | -- | -$0.68 | $0.39 | -$1.07 |
08/05/2021 | Q2 | -- | -- | -$0.82 | $0.44 | -$1.26 |
05/06/2021 | Q1 | -- | -- | -$0.55 | $0.29 | -$0.84 |
02/17/2021 | Q4 | -- | -- | $0.05 | $0.44 | -$0.39 |
11/05/2020 | Q3 | -- | -- | -$0.66 | $0.37 | -$1.03 |
08/06/2020 | Q2 | -- | -- | -$1.71 | $0.19 | -$1.90 |
05/07/2020 | Q1 | -- | -- | -$0.89 | $0.08 | -$0.97 |
02/20/2020 | Q4 | -- | -- | -$2.32 | $0.34 | -$2.66 |
11/07/2019 | Q3 | -- | -- | -$0.88 | $0.44 | -$1.32 |
08/08/2019 | Q2 | -- | -- | $0.66 | $0.57 | $0.09 |
05/09/2019 | Q1 | -- | -- | $0.48 | $0.44 | $0.04 |
02/21/2019 | Q4 | -- | -- | $0.51 | $0.43 | $0.08 |
11/08/2018 | Q3 | -- | -- | $0.59 | $0.66 | -$0.07 |
07/31/2018 | Q2 | -- | -- | $0.68 | $0.65 | $0.03 |
05/01/2018 | Q1 | -- | -- | $0.49 | $0.46 | $0.03 |
02/15/2018 | Q4 | -- | -- | $0.47 | $0.47 | $0.00 |
11/01/2017 | Q3 | -- | -- | $0.55 | $0.53 | $0.02 |
08/03/2017 | Q2 | -- | -- | $0.60 | $0.65 | -$0.05 |
05/04/2017 | Q1 | -- | -- | $0.52 | $0.53 | -$0.01 |
02/23/2017 | Q4 | -- | -- | $0.61 | $0.57 | $0.04 |
11/03/2016 | Q3 | -- | -- | $0.79 | $0.69 | $0.10 |
07/28/2016 | Q2 | -- | -- | $0.71 | $0.68 | $0.03 |
04/28/2016 | Q1 | -- | -- | $0.45 | $0.35 | $0.10 |
02/19/2016 | Q4 | -- | -- | $0.39 | $0.41 | -$0.02 |
11/09/2015 | Q3 | -- | -- | $0.51 | $0.51 | -- |
CommScope Holding reported $1.1B worth of top line sales in its most recent quarter.
CommScope Holding announced earnings per share of $2.88 which represents a beat of analyst forecast a $0.07 per share.
CommScope Holding reported $468.6M that represents $1.72 per share over the last quarter.
CommScope Holding's earnings are forecast to decrease from -$1.78 per share to $0.03 per share next year representing a decrease of -98.75%.
CommScope Holding's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.